Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail?

被引:42
|
作者
Nguyen, T. N. [1 ,2 ,3 ,4 ]
Cumming, R. G. [4 ]
Hilmer, S. N. [1 ,2 ,3 ]
机构
[1] Univ Sydney, Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW 2006, Australia
[2] Univ Sydney, Royal N Shore Hosp, Dept Aged Care, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Sydney, NSW 2006, Australia
[4] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia
关键词
atrial fibrillation; frailty; anticoagulant; anti-arrhythmic; stroke; bleeding; ANTICOAGULATION THERAPY; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULATION; MAJOR HEMORRHAGE; HEART-FAILURE; HIGH-RISK; WARFARIN; STROKE; DIGOXIN; IMPACT;
D O I
10.1111/imj.12912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundFrailty is common in patients with atrial fibrillation and may impact on antithrombotic and anti-arrhythmic treatment. AimTo describe differences in clinical characteristics, prescription of antithrombotic and anti-arrhythmic medications and incidence of haemorrhage and stroke, between frail and non-frail older inpatients. MethodsProspective observational study in patients aged 65years with atrial fibrillation admitted to a teaching hospital in Sydney, Australia. Frailty was assessed using the Reported Edmonton Frail Scale, stroke risk with CHA2DS2-VASc score and bleeding risk with HAS-BLED score. Participants were followed after 6months for haemorrhages and strokes. ResultsWe recruited 302 patients (mean age 84.7 7.1years, 53.3% frail, 50% female, mean CHA2DS2-VASc 4.61 +/- 1.44, mean HAS-BLED 2.97 +/- 1.04). Frail participants were older and had more co-morbidities and higher risk of stroke but not haemorrhage. Upon discharge, 55.7% participants were prescribed with anticoagulants (49.3% frail, 62.6% non-frail, P = 0.02). Thirty-three per cent received antiplatelets only and 11.1% no antithrombotics, with no difference by frailty status. For anti-arrhythmics, 52.6% received rate-control drugs only, 11.8% rhythm-control drugs only and 13.5% both and 22.1% were not prescribed either, with no difference by frailty status. On univariate logistic regression, frailty decreased the likelihood of anticoagulant prescription (odds ratio (OR) 0.58, 95%CI 0.36-0.93), but this was not significant on multivariate analysis (OR 0.66, 95%CI 0.40-1.11). After 6months, overall incidence of ischaemic stroke was 2.1%, and in patients taking anticoagulants, incidence of major/severe bleeding was 6.3%, with no significant difference between frailty groups. ConclusionsFrailty status had little impact on antithrombotic prescription and no impact on anti-arrhythmic prescription.
引用
收藏
页码:86 / 95
页数:10
相关论文
共 47 条
  • [11] Comparison between frail and non-frail older adults' gut microbiota: A systematic review and meta-analysis
    Almeida, Helena Maia
    Sardeli, Amanda, V
    Conway, Jessica
    Duggal, Niharika Arora
    Cavaglieri, Claudia Regina
    AGEING RESEARCH REVIEWS, 2022, 82
  • [12] Differential correlations of DHEA-S levels with knee strength and power between frail and non-frail older adults.
    Leng, SX
    Beamer, BA
    Andersen, RE
    Koenig-Stoffel, K
    Walston, JD
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S185 - S185
  • [13] Identifying Specific Drugs Classes That Result in Adverse Drug Reactions Between Frail and Non-Frail Hospitalized Older Adults.
    Cheong, S.
    Ong, E. H.
    Goh, W.
    Karim, S. B. Abdul
    See, L.
    Chong, E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S87 - S88
  • [14] Novel anticoagulants in an older and frail population with atrial fibrillation: the effect of inappropriate dosing on clinical outcomes
    José Paulo Henriques Cabral Lopes de Almeida
    Ana Sofia Martinho
    Adriana Girão
    Ivo Barreiro
    James Milner
    Maria João Vidigal Ferreira
    Armando Carvalho
    Rui Terenas Baptista
    Lino Gonçalves
    European Geriatric Medicine, 2020, 11 : 813 - 820
  • [15] Safety of dabigatran etexilate in frail older old patients with non-valvular atrial fibrillation
    Rodriguez Pascual, C.
    Paredes-Galan, E.
    Vilches-Moraga, A.
    Basalo-Carbajales, M. C.
    Guitian, A.
    EUROPEAN HEART JOURNAL, 2013, 34 : 96 - 96
  • [16] Novel anticoagulants in an older and frail population with atrial fibrillation: the effect of inappropriate dosing on clinical outcomes
    de Almeida, Jose Paulo Henriques Cabral Lopes
    Martinho, Ana Sofia
    Girao, Adriana
    Barreiro, Ivo
    Milner, James
    Ferreira, Maria Joao Vidigal
    Carvalho, Armando
    Baptista, Rui Terenas
    Goncalves, Lino
    EUROPEAN GERIATRIC MEDICINE, 2020, 11 (05) : 813 - 820
  • [17] Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation
    Giugliano, Robert P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : A1 - A10
  • [18] Using the FRAIL scale to compare pre-existing demographic lifestyle and medical risk factors between non-frail, pre-frail and frail older adults accessing primary health care: a cross-sectional study
    Aznar-Tortonda, Vanessa
    Palazon-Bru, Antonio
    Francisco Gil-Guillen, Vicente
    PEERJ, 2020, 8
  • [19] Assessment of the bleeding risk of anticoagulant treatment in non-severe frail octogenarians with atrial fibrillation
    Shinohara, Masaya
    Fujino, Tadashi
    Yao, Shinntaro
    Yano, Kensuke
    Akitsu, Katsuya
    Koike, Hideki
    Kinoshita, Toshio
    Yuzawa, Hitomi
    Suzuki, Takeya
    Kobayashi, Kenzaburo
    Ikeda, Takanori
    JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 7 - 13
  • [20] Dose-Response Relationships between Diet Quality and Mortality among Frail and Non-Frail Older Adults: A Population-Based Kyoto-Kameoka Prospective Cohort Study
    Watanabe, Daiki
    Yoshida, T.
    Nanri, H.
    Watanabe, Y.
    Itoi, A.
    Goto, C.
    Ishikawa-Takata, K.
    Yamada, Y.
    Fujita, H.
    Miyachi, M.
    Kimura, M.
    JOURNAL OF NUTRITION HEALTH & AGING, 2023, 27 (12): : 1188 - 1195